Salesforce has been battered in 2026. Bank of America sees more losses ahead

Bank of America reinstated Salesforce with an underperform rating and a $160 price target, implying about 8% downside from Friday's close. The firm argues Salesforce's AI transition could limit net new customer additions, upsell potential, and monetization, modeling growth at roughly 10% annually. Salesforce shares are already down about 35% year to date, and BofA says its AI initiatives added less than 2% to top-line growth last quarter.

Analysis

This is less about one analyst call and more about the market repricing CRM from a “platform compounding” story to a “software utility with capped expansion” story. The key second-order effect is that AI can improve customer outcomes without accruing proportionate SaaS revenue, which compresses the long-duration growth multiple even if product adoption stays healthy. That matters because the stock has likely been trading on an implicit belief that AI would reaccelerate monetization; if the monetization lag persists, multiple compression can continue even before fundamentals visibly break.

The real competitive risk is not that AI destroys CRM overnight, but that it shifts budget power toward lower-ACV point solutions and infrastructure layers that sit closer to the workflow. If copilots and agents reduce the need for incremental seats, upsell math deteriorates first in enterprise expansions, then in renewal pricing power. That creates a slower-burn headwind to gross retention and sales efficiency, which is harder for the market to underwrite than a one-time revenue miss.

Catalyst-wise, the next 1-2 quarters are about proof points on AI contribution and net-new bookings quality, not just headline growth. If AI remains immaterial while RPO and cRPO trends soften, the market will likely extrapolate a multi-year deceleration, not a temporary digestion. The contrarian angle is that the setup may already be crowded to the downside after a large YTD de-rating, so a clean earnings beat with stable guidance could trigger a sharp short-covering rally even if the long-term thesis is intact.

BAC’s call is also a sentiment signal for the broader enterprise software complex: names with vague AI roadmaps and stretched multiples are vulnerable, while vendors with measurable AI attach rates should outperform. In that sense, the opportunity is less about shorting CRM outright and more about expressing relative underperformance versus software with clearer monetization or more cyclical leverage.

Key Decisions for Investors

• Short CRM into any post-earnings strength; prefer a 4-8 week horizon with a tight stop above the prior reaction high, targeting further multiple compression as AI monetization remains subscale.
• Pair trade: long MSFT or NOW vs short CRM over the next 1-3 months to isolate relative AI monetization quality; the long leg has clearer pricing power and broader AI attach, while CRM carries higher narrative risk.
• Buy CRM put spreads 2-3 months out rather than outright puts; this captures downside if guidance disappoints while limiting theta bleed if the stock stabilizes after the recent de-rating.
• For longs, favor software names with visible AI revenue attach or mission-critical workflows over CRM in new capital allocation; relative performance should widen if the market keeps discounting “AI-enhanced but not AI-monetized” stories.